Top Page
Tern plc
(LSE:TERN)
Tern plc (TERN) vs. iShares MSCI United Kingdom ETF (EWC)
Tern plc Business Overview & Revenue Model
Tern plc Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.40K | 17.40K | 199.23K | -8.34M | 6.10M | 2.14M |
| Gross Profit | 29.40K | 17.40K | 199.23K | 66.01K | 63.78K | 151.16K |
| EBITDA | -1.13M | -1.18M | -12.67M | -10.25M | 0.00 | 0.00 |
| Net Income | -2.07M | -3.77M | -12.61M | -10.45M | 4.58M | 803.89K |
Balance Sheet | ||||||
| Total Assets | 10.94M | 11.31M | 13.15M | 25.18M | 32.76M | 24.30M |
| Cash, Cash Equivalents and Short-Term Investments | 74.00K | 382.21K | 297.56K | 931.76K | 1.96M | 2.13M |
| Total Debt | 170.00K | 161.11K | 418.20K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 655.00K | 597.62K | 848.44K | 325.00K | 342.06K | 295.60K |
| Stockholders Equity | 10.29M | 10.71M | 12.30M | 24.85M | 32.42M | 24.00M |
Cash Flow | ||||||
| Free Cash Flow | -1.16M | -1.57M | -1.22M | -2.20M | -1.48M | -1.19M |
| Operating Cash Flow | -1.16M | -1.57M | -1.22M | -2.20M | -1.48M | -1.19M |
| Investing Cash Flow | -442.39K | -406.39K | 151.92K | -1.63M | -2.50M | -1.86M |
| Financing Cash Flow | 1.55M | 1.65M | 431.54K | 2.80M | 3.81M | 4.17M |
Tern plc Technical Analysis
Tern plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | £197.76M | 47.35 | 9.59% | 0.80% | 22.80% | -32.13% | |
60 Neutral | £44.86M | 268.18 | ― | ― | 1.73% | -68.87% | |
58 Neutral | £5.26M | ― | ― | ― | ― | ― | |
51 Neutral | £1.74M | 56.67 | 0.89% | ― | ― | ― | |
43 Neutral | £4.04M | -7.50 | -19.70% | ― | -77.04% | 86.67% | |
39 Underperform | £2.44M | -0.34 | -213.44% | ― | 5.29% | 72.50% |
Tern plc Corporate Events
Tern Plc has announced that investor presentation materials from its recent online event featuring portfolio companies Device Authority and Talking Medicines are now available to view via published links, with a recording of the session to be hosted shortly on the company’s website. By making these detailed presentations and the event recording accessible, Tern is enhancing transparency and engagement with investors, offering deeper insight into the progress and prospects of its key IoT-focused holdings, which may help support stakeholder understanding of the portfolio’s development and strategic positioning.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.68 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern Plc has scheduled an online investor presentation and Q&A session for 5.30 p.m. GMT on Wednesday 7 January 2026, to be led by members of its management team alongside executives from portfolio companies Device Authority and Talking Medicines. The event, open to both existing and prospective shareholders, is designed to provide direct engagement with management and greater visibility into Tern’s portfolio, underlining the company’s efforts to enhance investor communication and transparency around its strategy and the progress of its IoT investments.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.63 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern Plc has been issued approximately £230,000 in new unsecured convertible loan notes by Talking Medicines Limited, in exchange for canceling existing short-term loans totaling about £180,000. This move increases Tern’s total convertible loan note holding in Talking Medicines to approximately £0.52 million while maintaining its 23.8% equity stake. Talking Medicines is raising up to £1.0 million through similar convertible loan notes to enhance its capabilities in the healthcare advertising market, which it aims to revolutionize with advanced data science and AI.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.63 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern Plc has announced an update regarding its capital commitment to Sure Valley Ventures Enterprise Capital Fund LP (SVV2). The company has invested approximately £1.3 million into SVV2 but faces challenges in meeting further capital calls due to insufficient funds and limited access to future funding. As a result, Tern has requested relief from its funding obligations, leading to its classification as a ‘defaulting investor’ under the SVV2 Limited Partnership Agreement. This status may affect Tern’s rights to distributions and recovery compared to non-defaulting investors. Despite these challenges, Tern aims to maintain its focus on protecting shareholder interests and long-term value creation from its key portfolio companies.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern Plc has announced the extension of the maturity dates for approximately £0.3 million of convertible loan notes in Talking Medicines Limited to 21 November 2029. This strategic move is expected to enhance Tern’s negotiating position for a potential exit from its investment in Talking Medicines, aligning the terms of the loan notes with previous agreements.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern plc announced that its total issued ordinary share capital consists of 672,713,705 Ordinary Shares, each with one voting right, and none held in Treasury. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:TERN) stock is a Sell with a £0.50 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Tern plc announced the results of its Open Offer, which closed on 14 October 2025, resulting in the issuance of 30,227,239 new Ordinary Shares and raising approximately £151,136. This move follows the failure to pass a resolution at the company’s AGM to issue new shares without pre-emption rights. The company is also implementing cost-saving measures, including a 50% salary reduction for directors and executive managers, to extend its cash runway into Q1 2026. Tern is exploring alternative funding solutions to meet its financial requirements, which may involve more costly or dilutive options.
The most recent analyst rating on (GB:TERN) stock is a Sell with a £0.50 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.